Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.

Breast Cancer Res Treat · 2024 · PMC10959799 · PMID 38216819

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

We did notice a trend toward decreased pCR rates with increasing BMI in the HR-/HER2 + subgroup ( N = 88, Table 3 ) which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.